Data as of May 17
| -0.11 / -0.48%|
The 10 analysts offering 12-month price forecasts for BioMed Realty Trust Inc have a median target of 23.25, with a high estimate of 26.00 and a low estimate of 19.00. The median estimate represents a +2.65% increase from the last price of 22.65.
The current consensus among 13 polled investment analysts is to Hold stock in BioMed Realty Trust Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.